Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Mezolar Matrix 37.5microgram/hour transdermal patches
0407020A0BFAFBW
|
Mezolar Matrix | Fentanyl | Central Nervous System | 5,450 |
|
Rivastigmine 13.3mg/24hours transdermal patches
0411000E0AAAIAI
|
Rivastigmine | Rivastigmine | Central Nervous System | 5,429 |
|
Durogesic DTrans 12micrograms/hour transdermal patches
0407020A0BBAMAU
|
Durogesic | Fentanyl | Central Nervous System | 5,369 |
|
Lurasidone 37mg tablets
0402010AIAAABAB
|
Lurasidone | Lurasidone | Central Nervous System | 5,344 |
|
Pericyazine 2.5mg tablets
0402010P0AAADAD
|
Pericyazine | Pericyazine | Central Nervous System | 5,344 |
|
Repinex XL 2mg tablets
0409010H0BFACAK
|
Repinex XL | Ropinirole hydrochloride | Central Nervous System | 5,336 |
|
Brancico XL 400mg tablets
0402010ABBLAEAY
|
Brancico XL | Quetiapine | Central Nervous System | 5,328 |
|
Safinamide 100mg tablets
0409010AAAAABAB
|
Safinamide | Safinamide | Central Nervous System | 5,311 |
|
Pregabalin 300mg tablets
0408010AEAAAWAW
|
Pregabalin | Pregabalin | Central Nervous System | 5,286 |
|
Cenobamate 200mg tablets
0408010ANAAADAD
|
Cenobamate | Cenobamate | Central Nervous System | 5,257 |
|
Aspirin 300mg tablets
0407010B0AAAFAF
|
Aspirin (Analgesic) | Aspirin | Central Nervous System | 5,251 |
|
Olanzapine 20mg orodispersible tablets sugar free
040201060AAAVAV
|
Olanzapine | Olanzapine | Central Nervous System | 5,243 |
|
Melatonin 1mg modified-release tablets
0401010ADAACUCU
|
Melatonin | Melatonin | Central Nervous System | 5,225 |
|
Pregabalin 100mg tablets
0408010AEAAAUAU
|
Pregabalin | Pregabalin | Central Nervous System | 5,217 |
|
Trazodone 50mg tablets
0403010X0AAAPAP
|
Trazodone hydrochloride | Trazodone hydrochloride | Central Nervous System | 5,141 |
|
Sodium valproate 300mg modified-release capsules
0408010W0AABRBR
|
Sodium valproate | Sodium valproate | Central Nervous System | 5,126 |
|
Brancico XL 200mg tablets
0402010ABBLABAW
|
Brancico XL | Quetiapine | Central Nervous System | 5,125 |
|
Repinex XL 4mg tablets
0409010H0BFAAAL
|
Repinex XL | Ropinirole hydrochloride | Central Nervous System | 5,121 |
|
Stalevo 150mg/37.5mg/200mg tablets
0409010X0BBACAC
|
Stalevo | Levodopa/carbidopa/entacapone | Central Nervous System | 5,102 |
|
Haloperidol 5mg/5ml oral solution sugar free
0402010J0AABCBC
|
Haloperidol | Haloperidol | Central Nervous System | 5,097 |
|
Gatalin XL 24mg capsules
0411000F0BFACAG
|
Gatalin XL | Galantamine | Central Nervous System | 5,093 |
|
Haloperidol 10mg tablets
0402010J0AAALAL
|
Haloperidol | Haloperidol | Central Nervous System | 5,070 |
|
Lacosamide 10mg/ml oral solution sugar free
0408010AHAAAGAG
|
Lacosamide | Lacosamide | Central Nervous System | 5,055 |
|
Nicorette invisi 25mg/16hours patches
0410020B0BBAVBR
|
Nicorette | Nicotine | Central Nervous System | 5,033 |
|
Rizatriptan 5mg tablets
0407041R0AAAAAA
|
Rizatriptan | Rizatriptan | Central Nervous System | 5,027 |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.